In two AML patients, a JAK1 mutation V623A was found, emphasizing the capacity of constitutively active JAK1 to induce a variety of leukemias (Xiang et al., 2008; Raivola et al., 2021). This evidence concerns the gene JAK1 and acute myeloid leukemia.